Teva Pharmaceutical Industries | TEVA - Net Income

Stock Price
10,090.00
Daily Change
-220.00 -2.13%
Monthly
6.78%
Yearly
66.67%
Q2 Forecast
9,793.35

Teva Pharmaceutical Industries reported $369M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Aspen Pharmacare ZAR 1.47B 4.94B Dec/2025
Cipla INR 6.76B 6.75B Dec/2025
Dr.Reddys Laboratories INR 2.21B 9.89B Mar/2026
Guangzhou Baiy CNY 1.78B 2.11B Mar/2026
Jiangsu Hengrui CNY 2.28B 322.38M Mar/2026
Kalbe Farma IDR 656.41B 241.76B Sep/2025
Richter Gedeon HUF 43.35B 8.49B Sep/2025
Sh Fosun Pharma CNY 870.83M 23.56M Mar/2026
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Teva Pharmaceutical Industries USD 369M 111M Mar/2026